title: Recombinant human soluble thrombomodulin counteracts capillary leakage associated with engraftment syndrome.
authors.forename: T
authors.initials: T
authors.lastname: Ikezoe
authors.forename: A
authors.initials: A
authors.lastname: Takeuchi
authors.forename: A
authors.initials: A
authors.lastname: Taniguchi
authors.forename: K
authors.initials: K
authors.lastname: Togitani
authors.forename: A
authors.initials: A
authors.lastname: Yokoyama
mesh_terms: D000368:Aged; D002199:Capillary Permeability / Q000187:drug effects*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000628:therapy; D011994:Recombinant Proteins; D012995:Solubility; D018180:Thrombomodulin / Q000627:therapeutic use*
chemical_list: D011994:Recombinant Proteins; C546931:THBD protein, human; D018180:Thrombomodulin